MedPath
TGA Approval

APO-ATAZANAVIR atazanavir 150 mg (as sulfate) capsule bottle (289527)

289527

APO-ATAZANAVIR atazanavir 150 mg (as sulfate) capsule bottle

Arrotex Pharmaceuticals Pty Ltd

May 14, 2018

Medicine

Medicine

Active

Registered

Active Ingredients

atazanavir sulfate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-ATAZANAVIR atazanavir 150 mg (as sulfate) capsule bottle (289527) - TGA 批准文号 | MedPath